Furthermore, several studies link BDNF Val66Met polymorphism to impaired cognitive functioning in PD, but it appears to be irrespective of dopamine replacement therapy and is a genotype-specific trait [57]. The gene discussed is BDNF; the disease is Parkinson disease.